Furthermore, in the respect of tumor chemotherapy resistance, progression-free survival (PFS) was significantly correlated with the TOP2A gene increases in platinum-resistant/refractory epithelial ovarian cancer (EOC)57. This evidence concerns the gene TOP2A and neoplasm.